Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggest that RNF43 is involved in tumorigenesis and progression of HCCs and that antagonism of RNF43 may be beneficial for HCC treatment.
|
23136185 |
2013 |
Pancreatic Cyst
|
0.010 |
Biomarker
|
disease |
BEFREE |
In recent years major advances in molecular technologies, including whole-exome sequencing, have significantly enhanced our knowledge of pancreatic premalignancy and have identified potentially highly specific diagnostic biomarkers such as mutations in GNAS and RNF43 that could be used to pre-operatively assess pancreatic cysts.
|
23442735 |
2013 |
Myeloperoxidase Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.
|
23620142 |
2013 |
Pancreatic Neoplasm
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Ubiquitin E3 ligase ring finger 43 (RNF43) has been suggested as a negative regulator of Wnt signaling, and mutations of RNF43 have been identified in various tumors, including cystic pancreatic tumors.
|
23847203 |
2013 |
Adenocarcinoma of pancreas
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
LGK974 inhibited proliferation and induced differentiation of RNF43-mutant pancreatic adenocarcinoma xenograft models.
|
23847203 |
2013 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
However, loss of function study of RNF43 in cell culture has not been conducted, and the functional significance of RNF43 mutations in cancer is unknown.
|
23847203 |
2013 |
Primary malignant neoplasm
|
0.100 |
GeneticVariation
|
group |
BEFREE |
However, loss of function study of RNF43 in cell culture has not been conducted, and the functional significance of RNF43 mutations in cancer is unknown.
|
23847203 |
2013 |
Pancreatic Ductal Adenocarcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
|
23847203 |
2013 |
ovarian neoplasm
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer.
|
24001777 |
2013 |
Ovarian Carcinoma
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Additionally, the absence of RNF43 mutations in other subtypes of ovarian carcinoma implicated that RNF43 mutations might not be actively involved in the pathogenesis of these disorders.
|
24001777 |
2013 |
Malignant neoplasm of ovary
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Additionally, the absence of RNF43 mutations in other subtypes of ovarian carcinoma implicated that RNF43 mutations might not be actively involved in the pathogenesis of these disorders.
|
24001777 |
2013 |
Carcinogenesis
|
0.090 |
GeneticVariation
|
phenotype |
BEFREE |
Recurrent RNF43 mutations existed in mucinous ovarian carcinomas implicated that these mutations might play crucial roles in the tumorigenesis of these patients, while the absence of DICER1, PPP2R1A, TRRAP and DNMT3A hot-spot mutations suggested that these genetic alterations might not play synergistic roles with RNF43 mutations in these individuals.
|
24001777 |
2013 |
Mucinous Adenocarcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recently, large-scale sequencing efforts have identified prevalent RNF43 mutations in pancreatic and ovarian mucinous carcinomas.
|
24001777 |
2013 |
Carcinoma, Ovarian Epithelial
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Additionally, the absence of RNF43 mutations in other subtypes of ovarian carcinoma implicated that RNF43 mutations might not be actively involved in the pathogenesis of these disorders.
|
24001777 |
2013 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
GNAS and RNF43 mutations have been discovered in most intraductal pancreatic mucinous neoplasms, providing critical molecular fingerprints for their diagnosis.
|
24436263 |
2014 |
SESSILE SERRATED POLYPOSIS CANCER SYNDROME
|
0.400 |
Biomarker
|
disease |
CLINGEN |
Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.
|
24512911 |
2014 |
polyps
|
0.030 |
GeneticVariation
|
phenotype |
BEFREE |
In 2 subjects,we found nonsense mutations in RNF43, indicating that it is also associated with multiple serrated polyps (odds ratio, 460; 95% confidence interval, 23.1–16,384; P = 6.8 x 10(-5)).
|
24512911 |
2014 |
Malignant neoplasm of stomach
|
0.320 |
Biomarker
|
disease |
CTD_human |
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
|
24816253 |
2014 |
Stomach Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
|
24816253 |
2014 |
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
|
24816253 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We evaluated somatic mutations of RNF43 and the expression of ring finger protein 43 as well as their associations with the molecular and clinicopathological features in 176 surgically resected intraductal papillary mucinous neoplasms.
|
25081753 |
2015 |
Pancreatic Intraductal Papillary Mucinous Neoplasm
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
These results indicate that RNF43 mutation might cause downregulation of the expression of ring finger protein 43 and play a crucial role and associate synergistically with GNAS mutation during development of intraductal papillary mucinous neoplasm of the pancreas.
|
25081753 |
2015 |
Colorectal Carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
RNF43 is frequently mutated in colorectal and endometrial cancers.
|
25344691 |
2014 |
Colorectal Neoplasms
|
0.330 |
Biomarker
|
group |
CTD_human |
RNF43 is frequently mutated in colorectal and endometrial cancers.
|
25344691 |
2014 |
Endometrial Carcinoma
|
0.320 |
Biomarker
|
disease |
CTD_human |
These results indicate that RNF43 is one of the most commonly mutated genes in colorectal and endometrial cancers.
|
25344691 |
2014 |